Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00261729 · ClinicalTrials.gov registry record · NA
Prazosin vs. Paroxetine in Combat Stress Symptoms in OIF/OEF Returnees
A NA study, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- NA
- Development phase
- 210
- Enrollment target
NCT00261729: Completed NA study, sponsored by US Department of Veterans Affairs.
NCT00261729 is a NA study that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 210 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00261729, a NA study, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- NA
- Development phase
- 210 participants
- Enrollment target
Study Summary
Evaluate the efficacy and tolerability of the drug prazosin compared to placebo for combat stress-related nightmares, sleep disturbance and overall function in recently combat-exposed returnees from OIF and OEF. To evaluate the effects of the SSRI paroxetine on behavioral symptoms and overall function in this population.
Interventions
- DRUG placebo
- DRUG Prazosin
- DRUG Paroxetine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 210 participants |
| Start Date | 2004-07 |
| Est. Completion | 2009-12 |
| Phase | NA |
What the finished NCT00261729 record still lists
NCT00261729 is an interventional study that assigns participants to a tested intervention. The registered 210 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower).
The record links to 0 conditions, and to 3 interventions - of which placebo is the first listed.
NCT00261729 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00261729 about?
NCT00261729 is a clinical study titled "Prazosin vs. Paroxetine in Combat Stress Symptoms in OIF/OEF Returnees". Evaluate the efficacy and tolerability of the drug prazosin compared to placebo for combat stress-related nightmares, sleep disturbance and overall function in recently combat-exposed returnees from OIF and OEF. To evaluate the effects of the SSRI paroxetine on behavioral symptoms and overall functi...
What is the current status of trial NCT00261729?
This trial is currently completed. It is a NA study. The enrollment target is 210 participants. The study started on 2004-07. Estimated completion is 2009-12.
What interventions are being tested in trial NCT00261729?
The interventions under investigation include: placebo (DRUG), Prazosin (DRUG), Paroxetine (DRUG).
Who is sponsoring clinical trial NCT00261729?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00261729's enrollment target sits among peer trials
210 490th of 2000 higher than 1,505 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02665923 · 210 participants
Gastric Emptying in Neonates and Infants After Formula Feeding
- NCT03322891 · 210 participants · NA
Improving Health Literacy in African-American Prostate Cancer Patients
- NCT03544489 · 210 participants · Phase 2
Effectiveness of Exercise After an ICD
- NCT04408430 · 210 participants · NA
The MITRAL II Pivotal Trial (Mitral Implantation of TRAnscatheter vaLves).
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia